Prostamax
🔹 What is Prostamax?
Class: Short peptide bioregulator derived from prostate tissue (Khavinson-style oral bioregulator, part of the same Cytomax/Cytogens family as Testagen and Ovagen). Mechanism:
- Signals to support the prostate’s own regenerative capacity and normal cellular function rather than supplying exogenous hormone or directly blocking any single receptor.
- Associated in the Russian/Eastern European bioregulator literature with support for prostate tissue health, urinary comfort, and general prostate maintenance, particularly in the context of age-related prostate changes (BPH-type complaints).
- Carries the same organ-specific, tissue-targeted signaling logic as the rest of the Cytomax/Cytogens line — narrow in scope, aimed at the tissue it’s derived from.
Primary focus:
- Prostate tissue maintenance and support, especially for men experiencing age-related prostate changes.
- General male urogenital comfort and function as part of a broader bioregulator protocol.
🔹 Oral Dosage (primary route) Range:
- 100 mcg per capsule, generally 1–2 capsules, 1–2 times daily, consistent with dosing conventions for this bioregulator family.
Frequency:
- Daily dosing for a minimum course of 20 days.
Rationale: As an oral bioregulator, Prostamax is designed for GI-stable short-peptide signaling to the prostate specifically — the goal is nudging the tissue’s own regulatory processes, not delivering a systemic hormonal or pharmacological effect.
🔹 Cycle Length Common cycle length: Minimum 20-day course, consistent with other bioregulators in this family. Off-cycle: Reassess symptoms/urinary function between courses before repeating; typically used as a structured short course rather than continuous daily use.
🔹 Optimal Dosing Window
- Taken with or around meals per label convention for oral bioregulators.
- Framed as a defined course rather than an ongoing daily supplement.
✅ Educational Integration Example (oral)
- Example protocol: 100 mcg, 1 capsule twice daily, for 20 days.
- Sometimes discussed alongside Testagen for a fuller male reproductive/urogenital picture, since the two target adjacent but distinct tissue (prostate vs. testicular).
🔹 Stacking Strategy (Educational / Complementary) Since Prostamax targets prostate tissue specifically, complementary stacks tend to focus on the broader male urogenital and hormonal picture: 🔸 Male Reproductive Axis Support:
- Testagen: Overlapping male-tissue bioregulator (testicular rather than prostate), sometimes paired for a more complete male-organ-system approach.
🔸 General Vitality & Recovery:
- Immune- and metabolism-supportive bioregulators can complement Prostamax’s narrow, organ-specific effect without duplicating its mechanism.
Rationale: Prostamax’s role is tissue-specific — the prostate — so stacking logic centers on either reinforcing the surrounding male reproductive axis or supporting general resilience alongside it.
Studied in Humans? Limited (primarily Russian/Eastern European research, minimal Western clinical trials)
FDA Approved? No
Allowed for 503a Compounding Pharmacy? No
Disclaimer: Do not rely on any dosing information provided, this is for educational and research only. Always double and triple check alternative references for education. Please consult with healthcare provider for your specific dosing and protocol if applicable.